Sabaa International Company for Pharmaceutical and Chemical Industry (EGX:SIPC)
Egypt · Delayed Price · Currency is EGP 4.830
-0.170 (-3.40%)
At close: Aug 4, 2026
EGX:SIPC Income Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 46.52 | 54.88 | 22.78 | 13.31 | 18.2 | 45.42 | |
Revenue Growth | 41.43% | 140.93% | 71.17% | -26.88% | -59.93% | -34.89% |
Cost of Revenue | 29.22 | 32.85 | 19.94 | 3.51 | 10.89 | 26.67 |
Gross Profit | 17.3 | 22.03 | 2.84 | 9.8 | 7.31 | 18.75 |
Selling, General & Admin | 9.38 | 8.69 | 6.29 | 6.48 | 5.72 | 9.85 |
Other Operating Expenses | 0.95 | 0.95 | -1.13 | -0.04 | - | - |
Operating Expenses | 10.33 | 9.69 | 11.58 | 6.45 | 5.73 | 9.9 |
Operating Income | 6.96 | 12.34 | -8.74 | 3.34 | 1.58 | 8.85 |
Interest Expense | -1.89 | -2.11 | -1.65 | -1.05 | -1.07 | -0.65 |
Currency Exchange Gain (Loss) | -1.65 | 1.32 | -8.66 | -0.62 | 0 | - |
Other Non Operating Income (Expenses) | - | - | - | 0.5 | 0.44 | 0.62 |
Pretax Income | 3.43 | 11.55 | -19.05 | 2.18 | 0.96 | 8.81 |
Income Tax Expense | 1.3 | 1.47 | -0.57 | 1.02 | 0.94 | 2.03 |
Net Income | 2.13 | 10.08 | -18.49 | 1.16 | 0.02 | 6.78 |
Preferred Dividends & Other Adjustments | - | - | - | 0.12 | 0 | 1.29 |
Net Income to Common | 2.13 | 10.08 | -18.49 | 1.04 | 0.01 | 5.49 |
Net Income Growth | - | - | - | 6989.94% | -99.73% | -54.37% |
Shares Outstanding (Basic) | 250 | 250 | 250 | 250 | 250 | 250 |
Shares Outstanding (Diluted) | 250 | 250 | 250 | 250 | 250 | 250 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | 0.01 | 0.04 | -0.07 | 0.00 | 0.00 | 0.02 |
EPS (Diluted) | 0.01 | 0.04 | -0.07 | 0.00 | 0.00 | 0.02 |
EPS Growth | - | - | - | 7075.86% | -99.74% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 11 | 10.76 | -2.08 | 2.09 | -17.29 | 3.44 |
Free Cash Flow Per Share | 0.04 | 0.04 | -0.01 | 0.01 | -0.07 | 0.01 |
Gross Margin | 37.18% | 40.14% | 12.47% | 73.63% | 40.17% | 41.28% |
Operating Margin | 14.97% | 22.49% | -38.38% | 25.13% | 8.70% | 19.48% |
Profit Margin | 4.57% | 18.37% | -81.15% | 7.82% | 0.08% | 12.09% |
Free Cash Flow Margin | 23.64% | 19.60% | -9.14% | 15.72% | -94.97% | 7.57% |
EBITDA | 9.98 | 15.84 | -5.65 | 6.56 | 5.4 | 12.06 |
EBITDA Margin | 21.45% | 28.87% | -24.80% | 49.31% | 29.68% | 26.55% |
D&A For EBITDA | 3.02 | 3.5 | 3.09 | 3.22 | 3.82 | 3.21 |
EBIT | 6.96 | 12.34 | -8.74 | 3.34 | 1.58 | 8.85 |
EBIT Margin | 14.97% | 22.49% | -38.38% | 25.13% | 8.70% | 19.48% |
Effective Tax Rate | 37.90% | 12.72% | - | 46.88% | 98.11% | 23.04% |
Advertising Expenses | - | - | 0 | 0 | 0.03 | - |